SISTEMA DE PRUEBA PARA DETERMINACIONES IN VITRO (IVD) DE ANTICUERPOS CONTRA SARS-COV-2
Mexico·Clase II·III. Agentes de
diagnóstico·INOCHEM S.A. DE C.V.·Registered May 22, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ANTI-SARS-COV-2-NCP ELISA (IGM)
- Trade Name (English)
- ANTI-SARS-COV-2-NCP ELISA (IGM)
- Analysis ID
- 1514R2024 SSA
- Registration Date
- May 22, 2024
- Name (Spanish)
- INOCHEM S.A. DE C.V.
- Name (English)
- INOCHEM S.A. DE C.V.
Access comprehensive regulatory information for SISTEMA DE PRUEBA PARA DETERMINACIONES IN VITRO (IVD) DE ANTICUERPOS CONTRA SARS-COV-2 (SISTEMA DE PRUEBA PARA DETERMINACIONES IN VITRO (IVD) DE ANTICUERPOS CONTRA SARS-COV-2) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1514R2024 SSA and manufactured by INOCHEM S.A. DE C.V.. The device was registered on May 22, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.